Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vose

Showing results (521-530 of 891) with videos related to

Pageof 90
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphomaJ O Armitage, J M Vose, J Linder, et al.
Experimental Neurology|October 12, 2021
Therapeutic acute intermittent hypoxia: A translational roadmap for spinal cord injury and neuromuscular diseaseAlicia K Vose, Joseph F Welch, Jayakrishnan Nair, et al.
Plastic and Reconstructive Surgery|June 25, 2011
Comparative healing of human cutaneous surgical incisions created by the PEAK PlasmaBlade, conventional electrosurgery, and a standard scalpelManuel E Ruidiaz, Davorka Messmer, Dominique Y Atmodjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancyJ M Vose, J E Anderson, P J Bierman, et al.
Bone Marrow Transplantation|January 2, 1997
Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrowJ E Talmadge, E Reed, K Ino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphomaY Yan, W C Chan, D D Weisenburger, et al.
Blood Reviews|August 31, 2015
Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?Javeed Iqbal, Ryan Wilcox, Hina Naushad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer InstitutesJulie M Vose, Laura A Levit, Patricia Hurley, et al.
Journal of the National Cancer Institute|June 15, 1988
Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21)J O Armitage, W G Sanger, D D Weisenburger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2021
<sup>18</sup>F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter studyRyogo Minamimoto, Luis Fayad, Julie Vose, et al.
Pageof 90

Showing results (521-530 of 891) with videos related to

Sort By:
Pageof 90
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphomaJ O Armitage, J M Vose, J Linder, et al.
Experimental Neurology|October 12, 2021
Therapeutic acute intermittent hypoxia: A translational roadmap for spinal cord injury and neuromuscular diseaseAlicia K Vose, Joseph F Welch, Jayakrishnan Nair, et al.
Plastic and Reconstructive Surgery|June 25, 2011
Comparative healing of human cutaneous surgical incisions created by the PEAK PlasmaBlade, conventional electrosurgery, and a standard scalpelManuel E Ruidiaz, Davorka Messmer, Dominique Y Atmodjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancyJ M Vose, J E Anderson, P J Bierman, et al.
Bone Marrow Transplantation|January 2, 1997
Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrowJ E Talmadge, E Reed, K Ino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphomaY Yan, W C Chan, D D Weisenburger, et al.
Blood Reviews|August 31, 2015
Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?Javeed Iqbal, Ryan Wilcox, Hina Naushad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer InstitutesJulie M Vose, Laura A Levit, Patricia Hurley, et al.
Journal of the National Cancer Institute|June 15, 1988
Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;q21)J O Armitage, W G Sanger, D D Weisenburger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2021
<sup>18</sup>F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter studyRyogo Minamimoto, Luis Fayad, Julie Vose, et al.
Pageof 90